ReviewAmerican journal of clinical dermatology2020

When is it OK to Stop Anti-Programmed Death 1 Receptor (PD-1) Therapy in Metastatic Melanoma?

Lauren B Banks et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.